Skip to the page

Data / Drug companies / Ipratropium bromide

Ipratropium bromide: 23 companies and 34 products in the FDA NDC directory

Ipratropium bromide is listed in the FDA National Drug Code Directory by 23 companies, with 34 products in commercial distribution. 33 of the products (97.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; spray, metered; spray, and the newest product started marketing on July 24, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
23
Products
34
Generic (ANDA) products
33 (97.1%)
Application numbers
17
Routes
Nasal, Respiratory (inhalation)
Brand names
Atrovent Hfa
openFDA record search
api.fda.gov

Companies that list ipratropium bromide

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions3solution; spray, meteredGeneric drugs (ANDA)May 26, 2020
Advagen Pharma Ltd2spray, meteredGeneric drugs (ANDA)January 14, 2025
Amneal Pharmaceuticals NY LLC2sprayGeneric drugs (ANDA)August 18, 2022
Apotex Corp.2spray, meteredGeneric drugs (ANDA)May 26, 2020
Bausch & Lomb Incorporated2spray, meteredGeneric drugs (ANDA)March 31, 2003
Bryant Ranch Prepack2sprayGeneric drugs (ANDA)November 5, 2003
Cardinal Health 107, LLC2solutionGeneric drugs (ANDA)July 24, 2026
Hikma Pharmaceuticals USA Inc.2sprayGeneric drugs (ANDA)November 5, 2003
Lupin Pharmaceuticals, Inc.2spray, meteredGeneric drugs (ANDA)July 3, 2025
NorthStar Rx LLC2spray, meteredGeneric drugs (ANDA)February 22, 2022
American Health Packaging1solutionGeneric drugs (ANDA)January 7, 2019
Aurobindo Pharma Limited1solutionGeneric drugs (ANDA)October 27, 2016
Boehringer Ingelheim Pharmaceuticals, Inc.1aerosol, meteredNew drug applications (NDA)May 1, 2005
Chartwell RX, LLC1solutionGeneric drugs (ANDA)September 27, 2001
Mylan Pharmaceuticals Inc.1solutionGeneric drugs (ANDA)November 9, 2010
Nephron Pharmaceuticals Corporation1solutionGeneric drugs (ANDA)September 27, 2001
NuCare Pharmaceuticals,Inc.1solutionGeneric drugs (ANDA)November 9, 2010
Oceanside Pharmaceuticals1spray, meteredGeneric drugs (ANDA)June 1, 2025
Redpharm Drug1solutionGeneric drugs (ANDA)February 1, 2011
Rising Pharma Holdings, Inc.1solutionGeneric drugs (ANDA)April 25, 2025
Ritedose Pharmaceuticals, LLC1solutionGeneric drugs (ANDA)February 1, 2011
Sportpharm LLC1spray, meteredGeneric drugs (ANDA)July 3, 2025
Sun Pharmaceutical Industries, Inc.1solutionGeneric drugs (ANDA)February 4, 2020

Dosage forms

Dosage formProductsShare
Solution1441.2%
Spray, metered1338.2%
Spray617.6%
Aerosol, metered12.9%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)3397.1%
New drug applications (NDA)12.9%

Pharmacologic classes

ClassProducts
Anticholinergic34

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.